NEW YORK, Jan. 8 — Bayer Diagnostic and Burrill & Company said Tuesday that they had formed a new $50 million venture capital fund for diagnostic research. The fund particularly seeks to back new applications of pharmacogenomic and proteomic technology in the diagnostic field.

 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.

The Associated Press reports that gene-edited food may soon be for sale.

The US Department of Health and Human Services is beginning a series of meetings on human fetal tissue research, Stat News reports.

In Cell this week: epigenetic change linked to glioblastomas, rare and low-frequency variants contributing to multiple sclerosis risk, and more.